Kuehbacher Tanja, Rehman Ateequr, Lepage Patricia, Hellmig Stephan, Fölsch Ulrich R, Schreiber Stefan, Ott Stephan J
Clinic for General Internal Medicine, I. Medical Department, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Brunswiker Str. 10, D-24105 Kiel, Germany.
Institute for Clinical Molecular Biology (IKMB), Christian-Albrechts-Universität (CAU) Kiel, Schittenhelmstr. 12, D-24105 Kiel, Germany.
J Med Microbiol. 2008 Dec;57(Pt 12):1569-1576. doi: 10.1099/jmm.0.47719-0.
TM7 is a recently described subgroup of Gram-positive uncultivable bacteria originally found in natural environmental habitats. An association of the TM7 bacterial division with the inflammatory pathogenesis of periodontitis has been previously shown. This study investigated TM7 phylogenies in patients with inflammatory bowel diseases (IBDs). The mucosal microbiota of patients with active Crohn's disease (CD; n=42) and ulcerative colitis (UC; n=31) was compared with that of controls (n=33). TM7 consortia were examined using molecular techniques based on 16S rRNA genes, including clone libraries, sequencing and in situ hybridization. TM7 molecular signatures could be cloned from mucosal samples of both IBD patients and controls, but the composition of the clone libraries differed significantly. Taxonomic analysis of the sequences revealed a higher diversity of TM7 phylotypes in CD (23 different phylotypes) than in UC (10) and non-IBD controls (12). All clone libraries showed a high number of novel sequences (21 for controls, 34 for CD and 29 for UC). A highly atypical base substitution for bacterial 16S rRNA genes associated with antibiotic resistance was detected in almost all sequences from CD (97.3 %) and UC (100 %) patients compared to only 65.1 % in the controls. TM7 bacteria might play an important role in IBD similar to that previously described in oral inflammation. The alterations of TM7 bacteria and the genetically determined antibiotic resistance of TM7 species in IBD could be a relevant part of a more general alteration of bacterial microbiota in IBD as recently found, e.g. as a promoter of inflammation at early stages of disease.
TM7是最近描述的革兰氏阳性不可培养细菌亚群,最初发现于自然环境栖息地。先前已表明TM7细菌分类与牙周炎的炎症发病机制有关。本研究调查了炎症性肠病(IBD)患者中的TM7系统发育。将活动期克罗恩病(CD;n = 42)和溃疡性结肠炎(UC;n = 31)患者的黏膜微生物群与对照组(n = 33)进行比较。使用基于16S rRNA基因的分子技术检查TM7聚生体,包括克隆文库、测序和原位杂交。TM7分子特征可从IBD患者和对照组的黏膜样本中克隆出来,但克隆文库的组成有显著差异。序列的分类分析显示,CD组(23种不同系统型)的TM7系统型多样性高于UC组(10种)和非IBD对照组(12种)。所有克隆文库都显示出大量新序列(对照组21条,CD组34条,UC组29条)。与对照组仅65.1%相比,在几乎所有CD患者(97.3%)和UC患者(100%)的序列中检测到与抗生素耐药性相关的细菌16S rRNA基因的高度非典型碱基替换。TM7细菌可能在IBD中发挥重要作用,类似于先前在口腔炎症中所描述的。IBD中TM7细菌的改变以及TM7物种的遗传决定抗生素耐药性可能是IBD中细菌微生物群更普遍改变的一个相关部分,例如作为疾病早期炎症的促进因素。